News about HIV

.@ScienceMagazine has named lenacapavir its 2024 Breakthrough of the Year. The success of the drug as pre-exposure prophylaxis (PrEP) sprang from a basic research advance on the structure and function of HIV’s capsid protein, which lenacapavir targets www.science.org/content/article/breakthrough-2024?utm_campaign=Science&utm_source=Bluesky&utm_medium=ownedSocial

At @ScienceMagazine, the Breakthrough of the Year 2024 Lenacapavir – a new injectable drug that prevents HIV infection "the long shot" by @sciencecohen www.science.org/doi/10.1126/science.adv2100 pic.x.com/Ktxang7rWU

Our investigational medication for #HIV prevention was named the 2024 Breakthrough of the Year, an annual honor Science gives to important developments. This recognition underscores the importance of our groundbreaking research and our commitment to help end the HIV epidemic. pic.x.com/cyf2oHzN07

#Lenacapavir is named @ScienceMagazine "2024 Breakthrough of the Year", Gilead to test once-a-year prevention shot, @iasociety updates #HIV treatment and prevention recommendations and more in this week's #NewsDigest. 📰 Read on and subscribe here! avac.org/weekly-newsdigest/ pic.x.com/uXcOe32kI0